Abstract
Ischemic stroke is a leading cause of death and cognitive impairment worldwide. However, the mechanisms of progressive cognitive decline following brain ischemia are not yet certain. Ongoing interest in cerebrovascular diseases research has provided data showing that Alzheimers proteins and other factors may be involved in the pathogenesis of gradual ischemic brain injury. Thus, both focal and global brain ischemia in rodents produces a stereotyped pattern of selective neuronal degeneration, which is just the same as in Alzheimers type dementia. Data from animal models and clinical studies of ischemic stroke have demonstrated an increase in expression and processing of amyloid precursor protein (APP) to a neurotoxic form of oligomeric β-amyloid peptide (Aβ) and hyperphosphorylation of tau protein. The authors of this review are using advances in methods and technologies to study cerebrovascular diseases and this review examines the hypothesis that pathological mechanisms common to both brain ischemia and Alzheimers dementia are contributing to cognitive impairment and brain ischemia-related dementia.
Keywords: Cerebrovascular diseases, stroke, dementia, cognition, Aβ, progenitor cells, chemoattractant, pericyte migration, endostatin/collagen, hindlimbs, inter-endothelial, mitogenic activity, gene occludin, complementary agents, cord blood cells
Current Neurovascular Research
Title: Cognitive Impairment with Vascular Impairment and Degeneration
Volume: 8 Issue: 4
Author(s): Ryszard Pluta, Jukka Jolkkonen, Salvatore Cuzzocrea, Felicita Pedata, David Cechetto and Aurel Popa-Wagner
Affiliation:
Keywords: Cerebrovascular diseases, stroke, dementia, cognition, Aβ, progenitor cells, chemoattractant, pericyte migration, endostatin/collagen, hindlimbs, inter-endothelial, mitogenic activity, gene occludin, complementary agents, cord blood cells
Abstract: Ischemic stroke is a leading cause of death and cognitive impairment worldwide. However, the mechanisms of progressive cognitive decline following brain ischemia are not yet certain. Ongoing interest in cerebrovascular diseases research has provided data showing that Alzheimers proteins and other factors may be involved in the pathogenesis of gradual ischemic brain injury. Thus, both focal and global brain ischemia in rodents produces a stereotyped pattern of selective neuronal degeneration, which is just the same as in Alzheimers type dementia. Data from animal models and clinical studies of ischemic stroke have demonstrated an increase in expression and processing of amyloid precursor protein (APP) to a neurotoxic form of oligomeric β-amyloid peptide (Aβ) and hyperphosphorylation of tau protein. The authors of this review are using advances in methods and technologies to study cerebrovascular diseases and this review examines the hypothesis that pathological mechanisms common to both brain ischemia and Alzheimers dementia are contributing to cognitive impairment and brain ischemia-related dementia.
Export Options
About this article
Cite this article as:
Pluta Ryszard, Jolkkonen Jukka, Cuzzocrea Salvatore, Pedata Felicita, Cechetto David and Popa-Wagner Aurel, Cognitive Impairment with Vascular Impairment and Degeneration, Current Neurovascular Research 2011; 8 (4) . https://dx.doi.org/10.2174/156720211798120981
DOI https://dx.doi.org/10.2174/156720211798120981 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Collecting Information for Rating Global Assessment of Functioning (GAF): Sources of Information and Methods for Information Collection
Current Psychiatry Reviews The Potential Therapeutic Role of the HMGB1-TLR Pathway in Epilepsy
Current Drug Targets Pleiotropic Effects of Cathepsin D
Endocrine, Metabolic & Immune Disorders - Drug Targets Diversity of Molecular Factors in Alzheimer’s Disease
Current Alzheimer Research Pharmacogenomics – Implications in the Development of HIV-Associated Brain Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Prion Protein Functions and Dysfunction in Prion Diseases
Current Medicinal Chemistry Biochemical Markers in CSF of ALS Patients
Current Medicinal Chemistry Assembly, Maturation, and Trafficking of the γ-Secretase Complex in Alzheimers Disease
Current Alzheimer Research QSAR and Molecular Docking Techniques for the Discovery of Potent Monoamine Oxidase B Inhibitors: Computer-Aided Generation of New Rasagiline Bioisosteres
Current Topics in Medicinal Chemistry CD36 as a Therapeutic Target for Endothelial Dysfunction in Stroke
Current Pharmaceutical Design The CSF p-tau181/Aβ42 Ratio Offers a Good Accuracy “In Vivo” in the Differential Diagnosis of Alzheimer’s Dementia
Current Alzheimer Research Activation of Brain Endothelium by Soluble Aggregates of the Amyloid-β Protein Involves Nuclear Factor-κB
Current Alzheimer Research PDE5 Inhibitors in Non-Urological Conditions
Current Pharmaceutical Design Anti-Inflammatory Drugs in the Treatment of Neurodegenerative Diseases: Current State
Current Pharmaceutical Design Using Non-Pharmacological Approaches for CJD Patient and Family Support as Provided by the CJD Foundation and CJD Insight
CNS & Neurological Disorders - Drug Targets Etanercept for the Treatment of Dermatological Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Editorial (Thematic Issue: Neurology and Genetics: How Molecular Biology is Changing the Neurological Thoughts?)
Current Molecular Medicine Release of Adenosine and ATP During Ischemia and Epilepsy
Current Neuropharmacology MicroRNAs: Macro Challenges on Understanding Human Biological Functions and Neurological Diseases
Current Molecular Medicine Albumin Infusion Therapy in Stroke, Sepsis and the Critically Ill
Current Nutrition & Food Science